2025-10-01T18:43:17-05:00 2024-06-30 320530003 QUIGLEY & MIRON 3580 WILSHIRE BLVD 1755 LOS ANGELES CA 90010 990 2023-07-01 813132011 MEDTECH INNOVATOR MEDT 7074666887 907 WESTWOOD BLVD 1067 LOS ANGELES CA 90024 PAUL GRAND CEO/PRESIDENT 7074666887 2025-10-01 0 ARMEN GRIGORIAN P01582463 2136393550 2023 2025-03-06 01:10:19Z PAUL GRAND 907 WESTWOOD BLVD 1067 LOS ANGELES CA 90024 2107883 0 X MEDTECHINNOVATOR.ORG X 2016 CA MEDTECH INNOVATOR ORGANIZES AND RUNS A GLOBAL COMPETITION AND VIRTUAL ACCELERATOR FOR MEDICAL DEVICE, DIGITAL HEALTH, AND DIAGNOSTIC STARTUP COMPANIES. 4 3 26 500 0 0 13316576 2052545 0 0 0 51313 0 0 13316576 2103858 826500 1224000 0 0 2268355 3299574 0 0 214323 858226 1148292 3953081 5671866 9363495 -3568008 14747390 11294121 235942 350681 14511448 10943440 X MEDTECH INNOVATOR ORGANIZES AND RUNS A GLOBAL COMPETITION AND VIRTUAL ACCELERATOR FOR MEDICAL DEVICE, DIGITAL HEALTH, AND DIAGNOSTIC STARTUP COMPANIES. 0 0 5016119 1224000 MEDTECH INNOVATOR ("MTI") IS THE LARGEST HEALTH CARE ACCELERATOR IN THE WORLD. ITS MISSION IS TO IMPROVE THE LIVES OF PATIENTS BY ACCELERATING THE GROWTH OF COMPANIES THAT ARE TRANSFORMING THE HEALTH CARE SYSTEM. WHILE MANY ENTITIES EXIST THAT PROVIDE EARLY-STAGE SUPPORT FOR HEALTH CARE INNOVATION, THESE ORGANIZATIONS COMMONLY ARE REGIONALLY BASED AND LIMITED BY THE FINANCIAL RESOURCES AND EXPERTISE OF THEIR LOCAL ECOSYSTEMS. AS A RESULT, PROMISING MEDICAL INNOVATIONS RECEIVE EARLY SUPPORT BUT ULTIMATELY FAIL TO REACH PATIENTS. MTI HAS BEEN PURPOSE-BUILT TO IDENTIFY THE MOST VIABLE STARTUPS AND IMMERSE THEM IN THE BEST VIRTUAL MEDTECH ECOSYSTEM IN THE WORLD, NO MATTER WHERE THEY ARE BASED. MTI PROVIDES A RESOURCE-RICH ENVIRONMENT TO ASSIST STARTUPS IN HONING THEIR BUSINESS MODELS, DEVELOPING THEIR VALUE PROPOSITIONS, AND SECURING THEIR NEXT ROUND OF FUNDING, AMONG OTHER CHALLENGES FACED BY COMPANIES ATTEMPTING TO COMMERCIALIZE INNOVATIVE HEALTH TECHNOLOGY FOR THE BENEFIT OF PATIENTS AROUND THE WORLD. MTI'S FLAGSHIP PROGRAM SUPPORTS MEDICAL DEVICE, DIGITAL HEALTH, AND DIAGNOSTIC STARTUPS AND SCALE-UPS. IN 2021, MTI LAUNCHED BIOTOOLS INNOVATOR, A NEWER INITIATIVE THAT LEVERAGES ITS SUCCESSFUL MODEL TO SUPPORT INNOVATORS IN THE LIFE SCIENCE TOOLS AND DIAGNOSTICS SPACES. 1. MTI UNDERTAKES TWO PRIMARY ACTIVITIES: SECTOR/REGIONAL-BASED COMPETITIONS FOR INNOVATIVE STARTUPS AND A FOUR-MONTH MENTORSHIP-DRIVEN ACCELERATOR FOR THE LEADING APPLICANTS. EACH YEAR, MTI GIVES OUT A COMBINATION OF CASH PRIZES AND IN-KIND AWARDS THROUGH ITS VARIOUS COMPETITIONS, WHICH INCLUDE SEVERAL ROUNDS DURING WHICH THOUSANDS APPLY AND HUNDREDS OF COMPANIES GAIN INCREASING AMOUNTS OF EXPOSURE TO INDUSTRY LEADERS THROUGH ONLINE APPLICATION REVIEWS, IN-PERSON AND VIRTUAL PITCH EVENTS, AND AUDIENCE-DRIVEN, PUBLIC COMPETITIONS IN PARTNERSHIP WITH LEADING INDUSTRY CONFERENCES. AS THE COMPETITION PROGRESSES, COMPANIES ARE ACCEPTED INTO THE ANNUAL COHORT. THESE STARTUPS GAIN CRITICAL INDUSTRY-WIDE VISIBILITY AND ACCESS TO LEADING INVESTORS, MANUFACTURERS, PROVIDERS, AND CUSTOMERS. AMONG MANY BENEFITS, THEY RECEIVE EXCLUSIVE NETWORKING OPPORTUNITIES, INTERACTIVE WORKSHOPS, AND COACHING. THE COMPANIES ALSO HAVE MULTIPLE OCCASIONS TO SHOWCASE THEIR PRODUCTS AND GAIN EXPERIENCE PITCHING TO AUDIENCES OF INDUSTRY STAKEHOLDERS AND DECISION-MAKERS. A SUBSET OF EARLIER-STAGE COMPANIES TAKE PART IN A CUSTOMIZED MENTORSHIP PROGRAM WHERE THEY ARE PAIRED WITH SENIOR LEADERS IN THE MEDICAL TECHNOLOGY (MEDTECH) OR LIFE SCIENCES INDUSTRIES. ALL COHORT COMPANIES HAVE THE OPPORTUNITY TO COMPETE FOR NON- DILUTIVE CASH PRIZES AND IN-KIND AWARDS.2. MTI HAS ATTRACTED TOP TALENT TO OVERSEE THE COMPETITION AND ACCELERATOR PROGRAMS, INCLUDING STAFF MEMBERS WITH ADVANCED DEGREES AND DOCTORATES IN FIELDS OF STUDY RELEVANT TO THE STARTUP COMPANIES THEY ASSIST. MTI STAFFERS HAVE A BROAD KNOWLEDGE AND UNDERSTANDING OF THE MEDICAL TECHNOLOGY AND LIFE SCIENCES INDUSTRIES, INCLUDING THE REGULATORY AND REIMBURSEMENT REQUIREMENTS, THE INVESTMENT ENVIRONMENT, AND THE CLINICAL AND SCIENTIFIC NEEDS FOR RESEARCH AND DEVELOPMENT. MTI ALSO DEVELOPS RELATIONSHIPS WITH HUNDREDS OF INDUSTRY EXECUTIVES, HEALTH CARE PROVIDERS, INVESTORS AND KEY OPINION LEADERS, FOR THE BENEFIT OF COMPANIES PARTICIPATING IN ITS COMPETITION AND ACCELERATOR. MTI BRINGS THESE EXPERTS TOGETHER TO SERVE AS APPLICATION REVIEWERS AND JUDGES AT REGIONAL PITCH EVENTS AND COMPETITIONS, AND THEY OFFER FEEDBACK, GUIDANCE AND MENTORSHIP TO COMPANIES THAT PROGRESS THROUGH THE PROGRAM. THESE EXPERTS VOLUNTEER THEIR TIME TO SUPPORT MTI IN ITS MISSION TO IMPROVE THE LIVES OF PATIENTS.3. THE EVENTS OF THE COMPETITION ARE CONDUCTED THROUGHOUT THE YEAR, WITH APPLICATIONS OPENING IN THE FALL SEASON OF THE PRECEDING YEAR. THE ACCELERATOR PROGRAMS TYPICALLY RUN FROM JUNE THROUGH OCTOBER.4. THE EVENTS OF THE COMPETITION AND ACCELERATOR TAKE PLACE VIRTUALLY AND IN CITIES AROUND THE UNITED STATES, SUCH AS SAN FRANCISCO, LOS ANGELES, SAN DIEGO, BOSTON, WASHINGTON, D.C., AND IN INTERNATIONAL LOCATIONS SUCH AS GERMANY, IRELAND AND SINGAPORE. THE ACCELERATOR IS A VIRTUAL PROGRAM, LARGELY CONDUCTED VIA WEBINAR AND TELECONFERENCE, IN ADDITION TO MULTI-DAY, IN-PERSON EVENTS HELD AT ITS BEGINNING AND CONCLUSION. ALL THE COMPANIES SELECTED FOR MEDTECH INNOVATOR'S ANNUAL COHORT PARTICIPATE IN THE INNOVATOR SUMMIT AND FINALS, WHICH BRING TOGETHER SENIOR LEADERSHIP FROM EACH COMPANY ALONG WITH REPRESENTATIVES FROM MEDTECH INNOVATOR'S CORPORATE PARTNERS, REPRESENTATIVES FROM FEDERAL AGENCIES THAT SUPPORT MEDICAL INNOVATION SUCH AS FDA, HHS, AND NIH; KEY STAKEHOLDERS SUCH AS INVESTORS, STRATEGIC MANUFACTURERS, SERVICE PROVIDERS, SPECIALTY ASSOCIATIONS AND SOCIETIES; AND HEALTH CARE PROVIDERS.5. MTI SEEKS TO IMPROVE THE LIVES OF PATIENTS BY ACCELERATING THE GROWTH OF STARTUP COMPANIES THAT ARE TRANSFORMING THE HEALTH CARE SYSTEM. THIS WILL BE ACCOMPLISHED BY OFFERING SUBSTANTIVE RESOURCES AND NETWORK CONNECTIONS TO THE STARTUPS LEADING UP TO AND DURING THE ACCELERATOR AS WELL AS PROVIDING DIRECT FUNDING TO SELECT COMPANIES THROUGH AWARDS IN THE COMPETITION. MTI'S ACTIVITIES FURTHER THE PUBLIC GOOD BY UNITING LEADING STAKEHOLDERS IN THE MEDTECH INNOVATION ECOSYSTEM TO SUPPORT AND GUIDE TRANSFORMATIVE EARLY-STAGE COMPANIES THAT ARE STRIVING TO SOLVE UNMET PATIENT NEEDS AND INCREASE EFFICIENCY, QUALITY, EQUITY AND VALUE IN THE HEALTH CARE SYSTEM. 6. MTI IS FUNDED BY CORPORATE INDUSTRY DONORS, INCLUDING LEADING MANUFACTURERS, PRIVATE FOUNDATIONS, INVESTORS, SERVICE PROVIDERS, STATE AND FEDERAL TRADE ASSOCIATIONS, GRANTS AND CONTRACTS FROM GOVERNMENTAL AGENCIES. MTI HOPES TO INCREASE FINANCIAL SUPPORT FROM GOVERNMENTAL AGENCIES, TRADE ASSOCIATIONS, AND PRIVATE FOUNDATIONS THAT SUPPORT HEALTH CARE INNOVATION, AS MTI PROVIDES A UNIQUE FRAMEWORK TO HELP ENSURE THAT IMPORTANT GRANT-SUPPORTED HEALTH CARE TECHNOLOGIES ACTUALLY REACH PATIENTS IN NEED.7. THERE CURRENTLY ARE NO DBAS. MTI'S WEBSITE IS HTTPS://MEDTECHINNOVATOR.ORG. 5016119 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 0 1 1 0 0 0 0 0 1 0 1 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 0 0 1 4 0 26 1 0 0 0 0 0 0 0 0 0 0 0 0 X 4 3 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X THE ORGANIZATION 3108241700 907 WESTWOOD BLVD 1067 LOS ANGELES CA 90024 CHRISTOPHER MARTIN DIRECTOR 3.00 X 0 0 0 PAUL GRAND CEO & PRESIDENT 50.00 X X 772578 0 57742 BIREN MEHTA DIRECTOR 2.00 X 0 0 0 KAREN JOHNSON DIRECTOR 2.00 X 0 0 0 KATHRYN ZAVALA COO 50.00 X 364375 0 24304 BRIAN BENSON SENIOR VICE PRESIDENT 40.00 X 227038 0 30243 AYELET MAROM VP, PROGRAMS 40.00 X 163390 0 28228 DIANE BOUIS DIRECTOR 40.00 X 133800 0 5232 DAPHNE AGHALARPOUR CHIEF OF STAFF 40.00 X 109000 0 11609 JERRY CIOLINO DIRECTOR OF OPERATIONS 40.00 X 101144 0 7940 1871325 0 165298 7 0 1 0 0 2052545 2052545 51313 51313 4025 4025 0 0 2103858 0 0 51313 901600 901600 322400 322400 1753548 1426172 205071 122305 1149987 1028536 88436 33015 46709 41603 3730 1376 187885 160172 19253 8460 161445 136666 16282 8497 5160 5160 25554 25554 192597 163037 19424 10136 112096 70270 27484 14342 135006 114285 13616 7105 4452 3769 449 234 135989 115117 13715 7157 5982 5064 603 315 20834 17637 2101 1096 EVENTS VENUES AND PRODU 505208 505208 MEALS AND ENTERTAINMENT 5414 4583 546 285 5671866 5016119 441424 214323 2575152 489980 2287404 11722305 7964463 440728 534052 25758 7536 9205 18222 14747390 11294121 99585 171674 136357 179007 235942 350681 X 2466363 2723355 12045085 8220085 14511448 10943440 14747390 11294121 -3568008 0 X X 0 1 X 1 0 X 3417724 4582114 3463152 13316576 2052544 26832110 3417724 4582114 3463152 13316576 2052544 26832110 16011575 10820535 2610 1089 51313 55012 26887122 0.40240 0.39100 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 25758 7536 18222 18222 ACCRUED PAYROLL 179007 179007 X PART X, LINE 2: ACCOUNTING STANDARDS REQUIRE AN ORGANIZATION TO EVALUATE ITS TAX POSITIONS AND PROVIDE FOR A LIABILITY FOR ANY POSITIONS THAT WOULD NOT BE CONSIDERED "MORE LIKELY THAN NOT" TO BE UPHELD UNDER A TAX AUTHORITY EXAMINATION. MANAGEMENT HAS EVALUATED ITS TAX POSITIONS AND HAS CONCLUDED THAT A PROVISION FOR A TAX LIABILITY IS NOT NECESSARY AT JUNE 30, 2024. GENERALLY, THE ORGANIZATION'S INFORMATION RETURNS REMAIN OPEN FOR EXAMINATION THREE (FEDERAL) OR FOUR (STATE OF CALIFORNIA) YEARS FROM THE DATE OF FILING. 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 GRANTS PRIZE MONEY FOR MEDICAL INNOVATION 312400 MIDDLE EAST 0 0 GRANTS PRIZE MONEY FOR MEDICAL INNOVATION 10000 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES MEETINGS AND EVENTS 40000 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES MEETINGS AND EVENTS 3000 0 0 0 0 0 0 365400 0 365400 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM PRIZE MONEY FOR MEDICAL INNOVATION 5400 BANK WIRE 0 MIDDLE EAST PRIZE MONEY FOR MEDICAL INNOVATION 10000 BANK WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM PRIZE MONEY FOR MEDICAL INNOVATION 250000 BANK WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM PRIZE MONEY FOR MEDICAL INNOVATION 25000 BANK WIRE 0 EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM PRIZE MONEY FOR MEDICAL INNOVATION 25000 BANK WIRE 0 0 0 0 0 0 0 PART I, LINE 3: THE ACCRUAL BASED METHOD ACCOUNTING WAS USED TO ACCOUNT FOR EXPENDITURES ;LISTTOTAL 43000 1 NEUROBIONICS 16 LINDEN AVENUE 8 SOMERVILLE MA 02143 931507973 8500 0 MTI 2024 VISION AWARD WINNER AOPIA BIOSCIENCES INC 1020 SERPENTINE LANE STE 110 PLEASANTON CA 94566 844772823 10000 0 BTI 2023 FINALIST AWARD ANDSON BIOTECH INC 58 EDGEWOOD AVENUE NORTHEAST LAB 124 ATLANTA GA 30303 874041250 10000 0 BTI 2023 FINALIST AWARD REELREACTOR INC 2601 NORTH PENROSE PLACE STAR ID 83669 921642843 10000 0 BTI 2023 BEST VIDEO AWARD INTERMED LABS LLC 10 MIRAMICHI TRAIL MORGANTOWN WV 26508 851751847 25000 0 MTI 2023 EARLY STAGE FINALIST AWARD NEURAVA INC 3000 KENT AVE SUITE 1158 WEST LAFAYETTE IN 47906 842192771 25000 0 MTI 2023 EARLY STAGE FINALIST AWARD SPARTA BIOMEDICAL INC 300 MAIN STREET 202 MADISON NJ 07940 842471988 10000 0 MTI 2023 EXECUTION AWARD IMMERSIVETOUCH 910 WEST VAN BUREN STREET CHICAGO IL 60607 134299221 35000 0 MTI 2023 AWARDS - BEST VIDEO & MID-STAGE FINALIST MICROTRANSPONDER 2802 FLINTROCK TRACE SUITE 226 AUSTIN TX 78738 208573833 200000 0 MTI 2023 MID-STAGE GRAND PRIZE AWARD ALYVE MEDICAL INC 600 S CHERRY ST STE 115 DENVER CO 80246 824058961 25000 0 MTI 2023 MID-STAGE FINALIST AWARD CARDIEX USA (ATCOR MEDICAL) 184 SHUMAN BOULEVARD SUITE 515 NAPERVILLE IL 60563 201110512 25000 0 MTI 2023 MID-STAGE FINALIST AWARD STROKEDX 271 S CHESTER AVENUE PASADENA CA 91106 874724805 350000 0 MTI 2023 EARLY STAGE GRAND PRIZE AWARD IFPX MEDICAL 9 EXECUTIVE CIRCLE SUITE 290 IRVINE CA 92614 990758700 25000 0 MTI 2023 EARLY STAGE FINALIST AWARD 13 PART I, LINE 2: COMPETITION ATTENDEES VOTE ON PRIZE WINNERS BASED ON MEDICAL INNOVATIONS PRESENTED. X X X 0 0 0 0 0 0 0 0 0 PAUL GRAND CEO & PRESIDENT 772578 0 0 0 0 0 13200 0 44542 0 830320 0 0 0 KATHRYN ZAVALA COO 364375 0 0 0 0 0 13200 0 11104 0 388679 0 0 0 BRIAN BENSON SENIOR VICE PRESIDENT 227038 0 0 0 0 0 8000 0 22243 0 257281 0 0 0 AYELET MAROM VP, PROGRAMS 163390 0 0 0 0 0 6000 0 22228 0 191618 0 0 0 ALISSA NIAL SISTER OF CEO PAUL GRAND 21335 DURING THE YEAR ENDED JUNE 30, 2024, MTI OBTAINED RECRUITING AND HUMAN RESOURCE SERVICES FROM A CORPORATION OWNED BY A SIBLING OF MTI'S CHIEF EXECUTIVE OFFICER. 0 FORM 990, PART VI, SECTION B, LINE 11B THE BOARD OF DIRECTORS REVIEWS THE FORM 990 PRIOR TO FILING THE RETURN. FORM 990, PART VI, SECTION B, LINE 12C BOARD MEMBERS ARE REQUIRED ANNUALLY TO REVIEW AND SIGN A CONFLICT OF INTEREST DISCLOSURE STATEMENT. THE ORGANIZATION'S CONFLICT OF INTEREST POLICY REQUIRES THAT A TRUSTEE SHALL EXCUSE HIMSELF OR HERSELF FROM ANY VOTE UPON WHICH SUCH TRUSTEE, OR ANY MEMBER OF HIS OR HER IMMEDIATE FAMILY, HAS A MATERIAL FINANCIAL INTEREST. PRIOR TO EACH VOTE ON ORGANIZATION MATTERS, TRUSTEES ARE ASKED TO ABSTAIN AS APPROPRIATE BASED ON THE CONFLICT OF INTEREST POLICY. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION HAS A COMPENSATION COMMITTEE FOR WHICH THE EXECUTIVE DIRECTOR'S COMPENSATION IS RESEARCHED AND AGREED UPON AND APPROVED. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION'S GOVERNING DOCUMENTS AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST. FORM 990, PART XII, LINE 2C: THE ORGANIZATION'S AUDIT COMMITTEE HAS RESPONSIBILITY FOR THE OVERSIGHT OF THE AUDIT OF ITS FINANCIAL STATEMENTS AND SELECTION OF THE INDEPENDENT AUDITOR, SUBJECT TO THE APPROVAL OF THE BOARD OF TRUSTEES. THIS RESPONSIBILITY IS UNCHANGED FROM THE PRIOR YEAR. MEDTECH INNOVATOR ASIA PACIFIC PTE LTD 51 GOLDHILL PLAZA 07-10/11 SINGAPORE SN COMPETITION FOR MEDICAL DEVICE, DIGITAL HEALTH, DIAGNOSTIC STARTUPS SN MEDTECH INNOVATOR 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MEDTECH INNOVATOR ASIA PACIFIC PTE LTD D 93324 CASH ADVANCES